Quick Answer
Armata Pharmaceuticals, Inc. reported Operating Income of -$36.63 million for fiscal year 2025.
Armata Pharmaceuticals, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$36.63M | +13.7% |
| 2024 | -$42.44M | -3.8% |
| 2023 | -$40.89M | -10.7% |
| 2022 | -$36.95M | -55.1% |
| 2021 | -$23.82M | -10.4% |
| 2020 | -$21.59M | -9.3% |
| 2019 | -$19.75M | -11.9% |
| 2018 | -$17.66M | -9.3% |
| 2017 | -$16.16M | +30.9% |
| 2016 | -$23.38M | -128.6% |
| 2015 | -$10.23M | +27.5% |
| 2014 | -$14.11M | -13.9% |
| 2013 | -$12.38M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.78M | +20.3% | -13.6% |
| June 30, 2025 | -$6.84M | +42.6% | +16.4% |
| March 31, 2025 | -$8.19M | +19.9% | +16.0% |
| September 30, 2024 | -$9.76M | +5.6% | +18.1% |
| June 30, 2024 | -$11.91M | -23.7% | -16.5% |
| March 31, 2024 | -$10.23M | +9.9% | +1.0% |
| September 30, 2023 | -$10.34M | -19.9% | -7.3% |
| June 30, 2023 | -$9.63M | -4.4% | +15.1% |
- Armata Pharmaceuticals, Inc. showed an increase of +13.7% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, Armata Pharmaceuticals, Inc.’s operating income has declined by 195.8% (from -$12.38 million to -$36.63 million).
- The most recent figure is from Armata Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: